demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
sarilumab high dose (400mg) Lescure ...

1 studies excluded by filtering options 0

5333 sarilumab phase 2 high dose, 0 013selection pending